Understanding the Prognostic Benefits of Exercise and Anti-Depressant Therapy (UPBEAT).
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Sertraline (Primary)
- Indications Depressive disorders
- Focus Biomarker; Therapeutic Use
- Acronyms UPBEAT
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2011 Planned number of patients changed from 200 to 150 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History